- Home
- SNDA vs INBX Comparison
SNDA vs INBX Comparison
Compare SNDA & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDA
- INBX
- Stock Information
- Founded
- SNDA 1990
- INBX 2010
- Country
- SNDA United States
- INBX United States
- Employees
- SNDA N/A
- INBX N/A
- Industry
- SNDA Hospital/Nursing Management
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- SNDA Health Care
- INBX Health Care
- Exchange
- SNDA Nasdaq
- INBX Nasdaq
- Market Cap
- SNDA 501.8M
- INBX 430.2M
- IPO Year
- SNDA 1997
- INBX 2020
- Fundamental
- Price
- SNDA $26.92
- INBX $35.08
- Analyst Decision
- SNDA Hold
- INBX Hold
- Analyst Count
- SNDA 1
- INBX 2
- Target Price
- SNDA $26.00
- INBX N/A
- AVG Volume (30 Days)
- SNDA 25.6K
- INBX 124.8K
- Earning Date
- SNDA 11-12-2025
- INBX 11-13-2025
- Dividend Yield
- SNDA N/A
- INBX N/A
- EPS Growth
- SNDA N/A
- INBX N/A
- EPS
- SNDA N/A
- INBX N/A
- Revenue
- SNDA $309,366,000.00
- INBX $1,400,000.00
- Revenue This Year
- SNDA $25.63
- INBX $563.00
- Revenue Next Year
- SNDA $6.18
- INBX $230.77
- P/E Ratio
- SNDA N/A
- INBX N/A
- Revenue Growth
- SNDA 26.39
- INBX N/A
- 52 Week Low
- SNDA $19.34
- INBX $10.81
- 52 Week High
- SNDA $28.97
- INBX $37.53
- Technical
- Relative Strength Index (RSI)
- SNDA 51.98
- INBX 71.28
- Support Level
- SNDA $26.22
- INBX $32.10
- Resistance Level
- SNDA $27.03
- INBX $37.53
- Average True Range (ATR)
- SNDA 0.70
- INBX 2.00
- MACD
- SNDA -0.16
- INBX 0.04
- Stochastic Oscillator
- SNDA 25.27
- INBX 73.31
About SNDA Sonida Senior Living Inc.
Sonida Senior Living Inc is an owner operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic service of the company is comprised of meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.